Skip to main content
Gary Hammer, MD, Endocrinology, Ann Arbor, MI, University of Michigan Medical Center

GaryDHammerMDPhD

Endocrinology • Ann Arbor, MI

Adrenal Disease

Professor of Internal Medicine; Molecular & Integrative Physiology; Cell & Developmental Biology - University Mich Medical School

Join to view full profile

Dr. Hammer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hammer's full profile

Already have an account?

Summary

  • Gary D. Hammer, M.D., Ph.D. is Professor in Departments of Internal Medicine (MEND), Cell & Developmental Biology, and Molecular & Integrative Physiology. He currently serves as Director of Endocrine Oncology Program in Rogel Cancer Center where he holds the Millie Schembechler Professorship in Adrenal Cancer. He is past Director of Center for Organogenesis: Stem Cells & Regenerative Medicine. He has brokered the recent renaissance of the current Michigan team of adrenal scientists that includes a who’s who in the study of adrenal disease. He received the UofM Jerome Conn Award for Outstanding Research in Internal Medicine, the Endocrine Society Edwin B. Astwood Award for Outstanding Research and is a member of ASCI and AAP. He has served in numerous leadership roles at UofM and in the public and private sectors including recent tenure on Board of Scientific Advisors for NCI. He is the editor of four textbooks including Pathophysiology of Disease: An Introduction to Clinical Medicine (McGraw Hilll), and the Adrenal Section Editor for Degroot’s Endocrinology (Elsevier). He has served in numerous capacities for the world’s largest endocrine organization, the Endocrine Society including his most recent role as President of the Society (2020-2021). An Advisor to the Congressional H.E.L.P. committee - he co-authored the 21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act’’ introduced in Congress in 2009. He has been catalyst for the formation of two international cooperative groups, most recently the A5 (American Australian Asian Adrenal Alliance) that leverages collaboration to secure projects from Pharma and funding agencies across the spectrum of adrenal diseases. He is a co- founder of two companies - MILLENDO and SLING THERAPEUTICS that focus on rare endocrine diseases.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Endocrinology, Diabetes, and Metabolism, 1994 - 1998
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 1992 - 1994
  • Tufts University Sackler School of Graduate Biomedical Sciences
    Tufts University Sackler School of Graduate Biomedical SciencesPhD, 1985 - 1992
  • Tufts University School of Medicine
    Tufts University School of MedicineClass of 1992
  • University of Vermont
    University of VermontBA, Psychology, Magna Cum Laude, 1981 - 1985

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1993 - Present
  • MI State Medical License
    MI State Medical License 2000 - 2026
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Elected Member American Association of Physicians, 2012
  • The One Hundred, Inductee Massachusetts General Hospital Cancer Center, 2014
  • America's Top Doctors Castle Connolly, 2011-2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Withanolides Are Potent Novel Targeted Therapeutic Agents against Adrenocortical Carcinomas  
    Subramanian C, Zhang H, Gallagher R, Hammer G, Timmermann B. and Cohen M, World Journal of Surgery, 6/1/2014
  • Abiraterone Acetate Added to Physiologic Hydrocortisone and Fludrocortisone Acetate Normalizes Androgen Excess in Adult Women With Classic 21-Hydroxylase Deficiency  
    Auchus RJ, Buschur EO, Chang AY, Hammer GD, Ramm C, Madrigal M, Wang G, Gonzalez M, Xu S, Smit JW, Jiao J and Yu MK, Journal of Clinical Endocrinology and Metabolism, 4/29/2014
  • Transcutaneous Biopsy of Adrenocortical Carcinoma Is Rarely Helpful in Diagnosis, Potentially Harmful, but Does Not Affect Patient Outcome  
    Williams A, Hammer GD, Else T, European Journal of Endocrinology, 1/1/2014
  • Join now to see all

Books/Book Chapters

  • Pathophysiology of Disease: An Introduction to Clinical Medicine 
    Editors: Hammer GD and McPhee SJ.LANGEEdition Seve,2014
  • CANCER: Principles & Practice of Oncology 
    Chapter: Adrenal Tumors 
    Lirov R, Else T, Lerario AM and Hammer GDEditors: DeVita, Jr. VT, Lawrence TS, and Rosenberg SA.Edition 10th,2014
  • Genetic Steroid Disorders 
    Editors: New ML, Lekarev O, Parsa O, Yuen, TT, O'Malley B, and Hammer GD.ELSEVIER2013
  • Join now to see all

Abstracts/Posters

  • International Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Linsitinib (OSI-906, L) in Patients (pts) with Locally Advanced or Metastatic Adrenocortic...
    Fassnacht M, Baudin E, Berruti A, Demeure MJ, Fleege T, Poondru S, Quinn DI, Rorig R, Hammer GD, The Endocrine Society Annual Meeting Abstracts, 1/1/2014
  • Sonic Hedgehog in Adrenal Regeneration
    Finco I, and Hammer GD, The Endocrine Society Annual Meeting Abstracts, 1/1/2014
  • Multiple Mechanisms of Wnt/Betacat-Mediated Inhibition of Adrenocortical Steroidogenesis
    Walczak EM, Finco I, Bohin N, Kuick R, & Hammer GD, The Endocrine Society Annual Meeting Abstracts, 1/1/2014
  • Join now to see all

Lectures

  • Career Development Workshop - Communications Skills Lab: How to Communicate Your Work to Media and Lay Public 
    ENDO 2019 - New Orleans, LA - 3/23/2019
  • 2019 Latin American Leadership Academy 
    ENDO 2019 - New Orleans, LA - 3/22/2019
  • Modeling Adrenal Tumorigenesis 
    ENDO 2019 - New Orleans, LA - 3/25/2019
  • Join now to see all

Other

Press Mentions

  • Gary D Hammer on the Improvement of Patient Care in Endocrine Neoplasia
    Gary D Hammer on the Improvement of Patient Care in Endocrine NeoplasiaDecember 23rd, 2019
  • Michigan Medicine's Division of Metabolism, Endocrinology and Diabetes Showcases New Research at Endocrine Society's ENDO 2018
    Michigan Medicine's Division of Metabolism, Endocrinology and Diabetes Showcases New Research at Endocrine Society's ENDO 2018March 17th, 2018
  • Adrenal Disorders Experts Address Rare Conditions and Their Treatment at American Association of Clinical Endocrinologists Scientific and Clinical Congress
    Adrenal Disorders Experts Address Rare Conditions and Their Treatment at American Association of Clinical Endocrinologists Scientific and Clinical CongressMay 5th, 2017
  • Join now to see all

Grant Support

  • Wnt-Responsive Adrenocortical Cells In Organ Maintenance And CancerNational Cancer Institute2010–2012
  • Mechanisms Of Adrenal DifferentiationNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2012
  • Mechanisms Of Adrenal Cortex Growth/DifferentiationNational Institute Of Diabetes And Digestive And Kidney Diseases2000
  • Orphan Nuclear Receptors In Development And DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2000
  • Orphan Nuclear Receptors In Development And DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1999

Professional Memberships

Hospital Affiliations

Dr. Gary Hammer, Dr. Gary Hammer, MD, Dr. G Hammer, Dr. Gary D Hammer